Analytical Data
-
基因名
NFIA
- Application
-
别名
NFIA；KIAA1439；Nuclear factor 1 A-type
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q12857
-
表达区间
1-509aa
-
氨基酸序列
MYSPLCLTQD EFHPFIEALL PHVRAFAYTW FNLQARKRKY FKKHEKRMSK EEERAVKDEL LSEKPEVKQK WASRLLAKLR KDIRPEYRED FVLTVTGKKP PCCVLSNPDQ KGKMRRIDCL RQADKVWRLD LVMVILFKGI PLESTDGERL VKSPQCSNPG LCVQPHHIGV SVKELDLYLA YFVHAADSSQ SESPSQPSDA DIKDQPENGH LGFQDSFVTS GVFSVTELVR VSQTPIAAGT GPNFSLSDLE SSSYYSMSPG AMRRSLPSTS STSSTKRLKS VEDEMDSPGE EPFYTGQGRS PGSGSQSSGW HEVEPGMPSP TTLKKSEKSG FSSPSPSQTS SLGTAFTQHH RPVITGPRAS PHATPSTLHF PTSPIIQQPG PYFSHPAIRY HPQETLKEFV QLVCPDAGQQ AGQVGFLNPN GSSQGKVHNP FLPTPMLPPP PPPPMARPVP LPVPDTKPPT TSTEGGAASP TSPTYSTPST SPANRFVSVG PRDPSFVNIP QQTQSWYLG
-
分子量
55.9 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human MAP4K4 Protein，GST
Cat：PA2000-9189
Recombinant Human PAPSS1 Protein，His
Cat：PA1000-2280
Protein Description
NFIA (Nuclear Factor I A) is a transcription factor essential for various biological processes, including neural development and the regulation of gene expression in the central nervous system. Its role in the regulation of glial and neuronal differentiation makes it a critical focus of study in neuroscience and developmental biology. NFIA has been implicated in various neurological disorders, which further emphasizes the need to understand its function and mechanisms. Researchers have been investigating the protein's structure and function, often utilizing recombinant DNA technology to produce NFIA in a laboratory setting. The generation of recombinant NFIA allows for the detailed study of its interactions with DNA and other proteins, ultimately contributing to our understanding of its role in development and disease. The ability to manipulate NFIA’s expression and activity provides researchers with valuable tools to explore potential therapeutic avenues for conditions linked to its dysregulation. As such, the study of NFIA and its recombinant forms continues to be a significant area of research in molecular biology and medicine.
